Tata Chemicals Limited
NSE:TATACHEM.NS
1120.25 (INR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 154,210 | 167,890 | 125,171.2 | 100,887.9 | 102,523.7 | 112,179.1 | 102,696.9 | 120,884.1 | 145,596.8 | 139,703.2 | 133,059.6 | 123,076.8 | 138,060.6 | 108,946.2 | 94,484.9 | 121,533.1 | 59,816.8 | 58,096 | 40,290.1 |
Cost of Revenue
| 82,140 | 62,710 | 30,155.7 | 26,795.8 | 23,081.7 | 25,020.7 | 20,993.1 | 44,707.2 | 76,509.6 | 72,558.8 | 65,244.5 | 60,065.8 | 75,971.8 | 91,966.4 | 77,063.5 | 103,937.6 | 73,418.6 | 23,606 | 18,264.9 |
Gross Profit
| 72,070 | 105,180 | 95,015.5 | 74,092.1 | 79,442 | 87,158.4 | 81,703.8 | 76,176.9 | 69,087.2 | 67,144.4 | 67,815.1 | 63,011 | 62,088.8 | 16,979.8 | 17,421.4 | 17,595.5 | -13,601.8 | 34,490 | 22,025.2 |
Gross Profit Ratio
| 0.467 | 0.626 | 0.759 | 0.734 | 0.775 | 0.777 | 0.796 | 0.63 | 0.475 | 0.481 | 0.51 | 0.512 | 0.45 | 0.156 | 0.184 | 0.145 | -0.227 | 0.594 | 0.547 |
Reseach & Development Expenses
| 950 | 30 | 30 | 41.6 | 45.1 | 364.3 | 337.5 | 349.6 | 842.8 | 600.4 | 511.8 | 151.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 30,720 | 910 | 823.1 | 631.7 | 454.2 | 351.1 | 322.2 | 348.5 | 428.9 | 434.4 | 438.9 | 381.6 | 5,057.7 | 0 | 0 | 0 | 13,800.7 | 12,221.7 | 7,180.3 |
Selling & Marketing Expenses
| 22,680 | 4,580 | 22,046.7 | 17,681.7 | 18,382.1 | 23,187.8 | 20,942.3 | 22,805.1 | 29,176.8 | 27,942.5 | 25,877.6 | 23,674.2 | 16,749.2 | 0 | 0 | 0 | 5,957.4 | 5,574.3 | 4,252.3 |
SG&A
| 53,400 | 5,490 | 22,869.8 | 18,313.4 | 18,836.3 | 23,538.9 | 21,264.5 | 23,153.6 | 29,605.7 | 28,376.9 | 26,316.5 | 24,055.8 | 21,806.9 | 0 | 0 | 0 | 19,758.1 | 17,796 | 11,432.6 |
Other Expenses
| 2,860 | 2,180 | 392.6 | 666.5 | 587.7 | 532.8 | 78 | 374.8 | 2,361.7 | -544.3 | 7,267.9 | 3,988.9 | 22,072.7 | 5,669.4 | 8,092.4 | 7,230.1 | 6,098.5 | 9,212.7 | 4,255.2 |
Operating Expenses
| 53,400 | 75,880 | 79,649.1 | 66,380.5 | 66,323.3 | 71,644.4 | 64,731.3 | 58,962.8 | 50,459.9 | 48,238.3 | 55,146.7 | 44,856.2 | 43,879.6 | 5,669.4 | 8,092.4 | 7,230.1 | 25,856.6 | 27,008.7 | 15,687.8 |
Operating Income
| 18,670 | 30,170 | 15,490 | 8,115.5 | 13,210.2 | 12,513.7 | 16,972.5 | 17,214.1 | 18,627.3 | 18,906.1 | 12,668.4 | 18,154.8 | 18,209.2 | 11,209.6 | 9,329 | 9,173.2 | -39,458.4 | 7,481.3 | 6,053.4 |
Operating Income Ratio
| 0.121 | 0.18 | 0.124 | 0.08 | 0.129 | 0.112 | 0.165 | 0.142 | 0.128 | 0.135 | 0.095 | 0.148 | 0.132 | 0.103 | 0.099 | 0.075 | -0.66 | 0.129 | 0.15 |
Total Other Income Expenses Net
| -11,050 | -2,770 | 1,180 | -1,775.6 | -729.6 | 1,858.9 | -771.2 | -2,648.1 | -5,913.3 | -7,321 | -17,857.3 | -9,024.5 | -4,374.9 | -100.8 | 0 | -1,192.2 | 51,217.1 | 0 | -330.9 |
Income Before Tax
| 7,620 | 27,400 | 16,666.3 | 6,339.9 | 12,480.6 | 17,417.5 | 16,201.3 | 14,566 | 12,714 | 11,585.1 | -5,188.9 | 9,130.3 | 13,834.3 | 11,209.6 | 9,329 | 9,173.2 | 11,758.7 | 7,481.3 | 6,006.5 |
Income Before Tax Ratio
| 0.049 | 0.163 | 0.133 | 0.063 | 0.122 | 0.155 | 0.158 | 0.12 | 0.087 | 0.083 | -0.039 | 0.074 | 0.1 | 0.103 | 0.099 | 0.075 | 0.197 | 0.129 | 0.149 |
Income Tax Expense
| 3,810 | 2,880 | 2,664.8 | 1,977.7 | 2,196.5 | 3,469.2 | 601.3 | 3,573.3 | 2,915.3 | 3,511.2 | 2,887.8 | 3,025.2 | 3,439.2 | 2,749.2 | 2,093.2 | 1,575.1 | 2,114.7 | 2,400.9 | 1,723.1 |
Net Income
| 2,680 | 23,170 | 12,580 | 2,563.7 | 70,063.3 | 11,559.1 | 24,330.8 | 9,931.1 | 7,801.6 | 5,964.6 | -10,320 | 4,004 | 10,395.1 | 8,460.4 | 7,235.8 | 7,598.1 | 9,644 | 5,080.4 | 4,283.4 |
Net Income Ratio
| 0.017 | 0.138 | 0.101 | 0.025 | 0.683 | 0.103 | 0.237 | 0.082 | 0.054 | 0.043 | -0.078 | 0.033 | 0.075 | 0.078 | 0.077 | 0.063 | 0.161 | 0.087 | 0.106 |
EPS
| 10.52 | 90.95 | 49.37 | 10.06 | 275.02 | 45.37 | 95.51 | 38.98 | 30.25 | 23.41 | -40.51 | 15.72 | 32.88 | 26.1 | 25.61 | 27.59 | 43.51 | 23.62 | 19.91 |
EPS Diluted
| 10.52 | 90.95 | 49.37 | 10.06 | 275.02 | 45.37 | 95.51 | 38.98 | 30.25 | 23.41 | -40.51 | 15.72 | 32.88 | 26.1 | 25.61 | 26.19 | 38.52 | 20.93 | 17.8 |
EBITDA
| 28,470 | 40,380 | 26,670.5 | 16,126.8 | 20,329.1 | 23,428.1 | 23,053 | 23,023 | 21,794.3 | 22,272 | 10,279.2 | 23,769.4 | 24,460 | 15,921.7 | 13,796.8 | 15,784 | -36,320.1 | 10,220.1 | 8,177.8 |
EBITDA Ratio
| 0.185 | 0.241 | 0.213 | 0.16 | 0.198 | 0.209 | 0.224 | 0.19 | 0.15 | 0.159 | 0.077 | 0.193 | 0.177 | 0.146 | 0.146 | 0.13 | -0.607 | 0.176 | 0.203 |